Hypertension is one of the most common chronic conditions in the U.S., affecting nearly half of the country’s adults, according to the Centers for Disease Control and Prevention. Unfortunately, ...

NEW YORK--(BUSINESS WIRE)--Clinical AI-powered healthcare company K Health announced today a new collaboration with Mayo Clinic’s digital healthcare initiative, Mayo Clinic Platform, which harnesses ...

Though it affects only somewhere between 0.1% and 1% of the world’s population, pulmonary hypertension can carry an outsized mortality risk. That’s due to its largely nonspecific symptoms—including ...

Digital health "unicorn" K Health teamed up with the Mayo Clinic to develop an artificial intelligence diagnosis model built to help doctors quickly identify better hypertension treatments for their ...

US-based AI company Anumana has revealed results from a study of an algorithm based on electrocardiogram (ECG) designed to recognise signs of pulmonary hypertension (PH) to expedite diagnosis.

CAMBRIDGE, Mass., March 28, 2026--(BUSINESS WIRE)--Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) ...

Please provide your email address to receive an email when new articles are posted on . At diagnosis, the area under the receiver operating characteristic curve in two test sets was 0.92 and 0.88.

A blood pressure program adopted across the University of California's six academic medical centers has effectively lowered hypertension and prevented serious disease or death for thousands of ...

The Apple Watch’s new HTNF algorithm now has FDA clearance to issue notifications when it detects patterns suggestive of hypertension Over a 30-day monitoring period, it uses optical sensor data and ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, a leader in cardiovascular AI, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for its pulmonary hypertension (PH) algorithm, an ...

Anumana has received 510(k) clearance from the US Food and Drug Administration (FDA) for its ECG-AI pulmonary hypertension (PH) detection algorithm, a software-as-a-medical-device (SaMD). The ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, Inc., an AI-driven health technology company from nference, Inc., today announced that the U.S. Food & Drug Administration (FDA) has granted Breakthrough ...